Clincosm LogoSign in Get a demo

hematologic cancer

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Research-Action in Hematology From Hospitalization to Home

Completed
  • Hematologic Cancer
  • additional follow-up extension at home
  • Caen, France
    CAEN University Hospital
Sep 22, 2023

Hematologic Cancer Trial (anxiety questionnaire)

Not yet recruiting
  • Hematologic Cancer
  • anxiety questionnaire
  • (no location specified)
Jul 11, 2023

Multiple Myeloma, Cancer, Hematologic Cancer Trial in Cork (Discontinuation of maintenance treatment)

Not yet recruiting
  • Multiple Myeloma
  • +2 more
  • Discontinuation of maintenance treatment
  • Cork, Ireland
    Cork University Hospital
May 10, 2023

Hematologic Cancer Trial in Israel, United States (ABBV-101)

Not yet recruiting
  • Hematologic Cancer
  • Lone Tree, Colorado
  • +7 more
Feb 22, 2023

Hematologic Cancer, Hematologic Malignancy Trial in Boston (CBT for Fatigue, Usual Care)

Not yet recruiting
  • Hematologic Cancer
  • Hematologic Malignancy
  • CBT for Fatigue
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 3, 2023

Avera/Sema4 Oncology and Analytics Protocol

Recruiting
  • Cancer
  • +11 more
    • Sioux Falls, South Dakota
      Avera Cancer Institute
    Jan 30, 2023

    Bone Marrow Cancer, Leukemia, Lymphoma Trial in Philadelphia (Virtual reality, Environmental changes)

    Enrolling by invitation
    • Bone Marrow Cancer
    • +4 more
    • Virtual reality
    • Environmental changes
    • Philadelphia, Pennsylvania
      Thomas Jefferson University Hospital
    Jan 9, 2023

    Multidimensional Aspects of QUAlity of Life After Cancer

    Recruiting
    • Solid Tumor
    • Hematologic Cancer
    • QoL & irAEs determinants
    • Pierre-Bénite, France
    • +4 more
    Nov 15, 2022

    Hematologic Cancer Trial (experimental:Acute leukemia/myelodysplastic or myeloproliferative disease)

    Not yet recruiting
    • Hematologic Cancer
    • experimental:Acute leukemia/myelodysplastic or myeloproliferative disease
    • (no location specified)
    Oct 26, 2022

    Oral Mucositis, Lymphoma, Multiple Myeloma Trial in Seoul (MIT-001, normal saline)

    Recruiting
    • Oral Mucositis
    • +3 more
    • Seoul, Korea, Republic of
    • +1 more
    Aug 9, 2022

    Cancer, Young Adult, Pain Trial in Durham (Behavioral Symptom Management for Young Adult Cancer Survivors)

    Recruiting
    • Cancer
    • +9 more
    • Behavioral Symptom Management for Young Adult Cancer Survivors
    • Durham, North Carolina
      Duke Cancer Institute
    Aug 2, 2022

    Solid Tumor, Adult, Solid Tumor, Childhood, Hematologic Cancer Trial in Villejuif (Tumor biopsy, Blood sample, Bone marrow

    Recruiting
    • Solid Tumor, Adult
    • +2 more
    • Tumor biopsy
    • +2 more
    • Villejuif, Val De Marne, France
      Gustave Roussy Cancer Campus Grand Paris
    Jul 28, 2022

    Financial Stress, Hematologic Cancer, Survivorship Trial in Lexington (CC Links)

    Completed
    • Financial Stress
    • +2 more
    • CC Links
    • Lexington, Kentucky
      University of Kentucky
    Jul 15, 2022

    Breast Cancer, Gastrointestinal Cancer, Hematologic Cancer Trial in Houston (OPTIMISE)

    Recruiting
    • Breast Cancer
    • +2 more
    • OPTIMISE
    • Houston, Texas
      Baylor College of Medicine
    May 16, 2022

    Neutropenia, Febrile, Hematologic Cancer Trial in Doha (Ceftolozane-tazobactam IV)

    Not yet recruiting
    • Neutropenia, Febrile
    • Hematologic Cancer
    • Ceftolozane-tazobactam IV
    • Doha, Qatar
      Hamad Medical Corporation, National Center for Cancer Care and R
    Apr 7, 2022

    Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

    Enrolling by invitation
    • Breast Cancer
    • +4 more
      • Seattle, Washington
        GBC
      Mar 14, 2022

      Evidence Determining Individualized Cancer Therapy for Incurable

      Terminated
      • Hematologic Cancer
      • Molecularly targeted treatment matched to genomic/immunophenotypic tumor profile (chosen by treating physician)
      • La Jolla, California
        UCSD Moore's Cancer Center
      Jan 31, 2022

      AML, MDS, Old Age; Debility Trial in Suzhou (Azacitidine, all trans retinoic acid)

      Recruiting
      • AML
      • +3 more
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Dec 27, 2021

      Allogeneic Disease, Hematologic Cancer, Cancer Rehabilitation Trial in Toronto (CaRE-4-alloBMT plus usual care group)

      Recruiting
      • Allogeneic Disease
      • +2 more
      • CaRE-4-alloBMT plus usual care group
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Sep 29, 2021

      CAncer, NUtrition and Taste - Validation of CANUT-QVA

      Completed
      • Hematologic Cancer
      • +5 more
      • Evaluation of the 9 dimensions of the CANUT-QVA questionnaire
      • Pierre-Bénite, France
        Hospices Civils de Lyon, Groupement Hospitalier Lyon Sud, Servic
      Jul 6, 2021

      Hematologic Cancer Trial (blood collection)

      Not yet recruiting
      • Hematologic Cancer
      • blood collection
      • (no location specified)
      Mar 26, 2021

      The Point of View of Hematological Cancer Patients and Their

      Unknown status
      • Hematologic Cancer
      • spirituality
      • (no location specified)
      May 29, 2020

      Hematologic Cancer Trial (elotuzumab, lenalidomide, dexamethasone oral)

      Completed
      Has Results
      • Hematologic Cancer
      • elotuzumab
      • +3 more
      • (no location specified)
      Jan 8, 2018

      Hematologic Cancer, Relapse Leukemia, Relapsed Adult ALL Trial in Montreal (GLIDE)

      Unknown status
      • Hematologic Cancer
      • +8 more
      • GLIDE
      • Montreal, Quebec, Canada
        CIUSSS d l'Est-de-l'Île-de-Montréal
      Dec 4, 2017